All posts by dIhgh48GHr48gv

Global Specimen Solutions, Inc. Announces New Board of Directors

GSS Builds Advisory Expertise for New Growth Phase of Company

February 24, 2015
Cary, North Carolina. – Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), an innovative specialty CRO focused on specimen management and informatics, announced today that Allen A Spizzo and Kay Gamble are joining the Board of Directors..

“Global Specimen Solutions, Inc. is excited to have two individuals with strong and diverse  business expertise  joining our Board of Directors to help guide our new growth phase for the company.  Mr. Spizzo brings global business and financial expertise to our Board, and will help guide our  financial development, planning and investment phases for informatics and growth.  Ms. Gamble brings international marketing expertise across chemical and biotechnology sectors to our Board, helping launch our international approaches to Global Specimen Solutions marketing.”  –Amelia Wall Warner, Founder and CEO.

Continue reading Global Specimen Solutions, Inc. Announces New Board of Directors

Global Specimen Solutions, Inc. Closes Series A Funding

GSS Builds Momentum for Specialty Specimen CRO Services and Infrastructure

Cary, North Carolina. – Global Specimen Solutions, Inc. (www.globalspecimensolutions.com), an innovative specialty CRO focused on specimen management and informatics, announced today that Series A funding was closed.

“Global Specimen Solutions, Inc. is excited to catapult our growing momentum in clinical specimen management with investment that will further enhance our proprietary informatics tools and infrastructure to build our first-to-market services supporting specimen research. GSS has proved rapid market uptake of our clinical trial management services and products for translational medicine, and this funding will help speed introduction of new proprietary tools to our growing client base.” –Amelia Wall Warner, Founder and CEO

Continue reading Global Specimen Solutions, Inc. Closes Series A Funding

Creating Paradigm Shifts Across the Globe

Bringing new business ideas to the market is tough. Even in the most innovative corporate cultures- there are significant ties to “how things have always been done”. Building vision for a better future for busy executives takes tenacity, time, and clarity of thought. It also requires unwavering belief in the ability of organizations and cultures to change.

Continue reading Creating Paradigm Shifts Across the Globe

Value of Strategic Partnership- Avoiding Repeated Swings and Misses

Today there is a large drive to be everything to everyone.  Clients want a strategic partner that can also provide all services they could possibly request and- let’s be honest- those of us in the service sector want to be that partner.  However, by attempting to constantly develop every expertise in-house, companies can migrate so far from their innovative core that they are no longer effective partners and are replaced by the next commodity provider with powerful marketing teams.

Continue reading Value of Strategic Partnership- Avoiding Repeated Swings and Misses

The View From Here

I was lucky enough to attend an ELSI 2.0 sponsored conference at the Centre for Law and Genomics in Tasmania, Australia. It was an amazing event, allowing ethicists, researchers, attorneys, and commercial providers to discuss what aspects of genomic research and human specimen research should be regulated- but more on that soon!

During the conference, one clear area of fundamental disagreement emerged amongst attendees- the fundamental question of whether learning insights on the impact of disease in large populations was of benefit to participants in this type of study. In other words, does advancing information that would benefit the “greater good” of future generations of patients qualify as a benefit to an individual deciding to participate in human specimen research. The divide was clear- most researchers expressed a strong belief in the ability of research to advance medicine, and thus to benefit participants by allowing this rapid advancement of knowledge during the lifetime of the research participant and the research participant’s family’s lifetime. Some Ethicists, however, were more cautious about whether research truly advances medicine at all, pointing to multiple examples of erroneous conclusions that contributed to harmful therapies or incorrect treatments being employed in large populations. Interesting…

Continue reading The View From Here

“Change” Management- Navigating Personal Change in a Professional Environment

When Schering-Plough announced its merger with Organon back in 2007, I was lucky to have a fabulous boss who immediately focused our entire organization on Change Management. Managers were trained well in advance of the official merger date, to handle the stress and anxiety of our direct reports (and personnel in general) as we approached a massive integration project for two large companies. It made a huge difference- those managers who had completed extensive Change Management training were able to better stabilize their teams to focus on a productive future.

Continue reading “Change” Management- Navigating Personal Change in a Professional Environment

If I Were 22- I Would Enjoy the Ride

If I were 22, I would try to let myself off the hook and really enjoy the ride. I would tell myself, “You will be successful on your own career path. All setbacks are not game-enders. AND- Your biggest joys in your professional life will not be directly related to your title or salary.”

1) You Will be Successful on YOUR own Career Path. Young, driven professionals worry about “doing the absolute right thing”. It is one of the reasons they are successful, but can also paralyze them when making decisions. If I could go back to my young, 22 year old self, I would say- calm down. You will be successful. Every career decision is adding to your tool kit that will ultimately drive your success, but there is no absolute right or wrong path to get there. I remember agonizing over where to accept a residency position, where to accept my first faculty position, whether to enter the corporate sector, whether to start my own business. Each time I made a decision, I knew a little more, grew a little more flexible, and grew a little more confident. I wish that young professionals who are driven to success could take a moment to breathe, search their minds and hearts for the best answer for THEM, and not worry about a right or wrong path. The truth is, the path you choose is YOUR path, and that is always the right one for you.

Continue reading If I Were 22- I Would Enjoy the Ride

What Legacy Do We Leave? Reflections from Mother’s Day

With Mother’s Day just passing, I was thinking about how being a professional impacts my daughters. Believe me- I have never been Gloria Steinem. But because of women like Steinem, Emmeline Pankhurst, Ellen Kullman, and others, I don’t have to be. I have had the luxury of working hard, being recognized for productivity and successes, and being promoted to key leadership positions throughout my career.

Continue reading What Legacy Do We Leave? Reflections from Mother’s Day

Refreshing Biorepository Science- A New Day for External Operations

Understanding the needs of biorepositories takes years of direct hands-on experience. Understanding how to run a translational research program that builds on the platforms of both prospective and high quality retrospective analysis is an art form. Truly refreshing an external storage model has been challenging, but needed in this industry.

Continue reading Refreshing Biorepository Science- A New Day for External Operations

Why Human Biospecimen Research and Storage is Not a Commodity Service Offering

<h1>Why Human Biospecimen Research and Storage is Not a Commodity Service Offering</h1>
Maintaining high quality human biospecimens with appropriate analyte integrity is more difficult than we had once believed. As biospecimen research expands and advances, we are learning how specimens must be procured, handled, and stored in much greater detail than in past decades, leading us to understand which specimen collections are still useful and which specimens are no longer viable for analysis.

Read the full article on Linkedin